United States · FDA National Drug Code directory

hydroxyzine pamoate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1265_d9e2251d-75ed-4306-b75c-20e1b145f931
Product NDC
71335-1265
Form
CAPSULE
Composition / generic term
hydroxyzine pamoate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20130603
Source listing expiry
20261231

Source-listed ingredients

  • HYDROXYZINE PAMOATE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE in 1 BOTTLE (71335-1265-1) · 71335-1265-1
  • 60 CAPSULE in 1 BOTTLE (71335-1265-2) · 71335-1265-2
  • 90 CAPSULE in 1 BOTTLE (71335-1265-3) · 71335-1265-3
  • 8 CAPSULE in 1 BOTTLE (71335-1265-4) · 71335-1265-4
  • 20 CAPSULE in 1 BOTTLE (71335-1265-5) · 71335-1265-5
  • 42 CAPSULE in 1 BOTTLE (71335-1265-6) · 71335-1265-6

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →